Healthcare Services company Inventurus Knowledge Solutions announced Q1FY27 results Consolidated Financial Highlights: Total Income: The consolidated total income for Q1FY27 was Rs 8,993.39 million, reflecting a YoY growth of 21.01% from Rs 7,432.08 million in Q1FY26 and a QoQ growth of 4.27% compared to Rs 8,625.25 million in Q4FY26. Revenue from Operations: Revenue in Q1FY27 stood at Rs 8,936.29 million, showing a YoY increase of 20.75% over Rs 7,400.95 million in Q1FY26 and a QoQ increase of 4.20% from Rs 8,576.52 million in Q4FY26. Net Profit: The Group reported a net profit of Rs 1,937.41 million for Q1FY27, representing a YoY growth of 27.85% from Rs 1,515.39 million in Q1FY26. On a QoQ basis, net profit saw a decline of 5.94% from Rs 2,059.68 million in Q4FY26. Standalone Financial Highlights: Total Income: Standalone total income for Q1FY27 was Rs 4,767.25 million, marking a YoY growth of 48.23% from Rs 3,216.18 million in Q1FY26 and a QoQ growth of 15.11% from Rs 4,141.44 million in Q4FY26. Revenue from Operations: Standalone revenue in Q1FY27 reached Rs 4,752.68 million, an increase of 48.77% YoY compared to Rs 3,194.69 million in Q1FY26 and a QoQ increase of 15.16% from Rs 4,126.91 million in Q4FY26. Net Profit: Net profit on a standalone basis was Rs 1,625.46 million for Q1FY27, representing a YoY growth of 44.01% from Rs 1,128.75 million in Q1FY26. On a QoQ basis, net profit decreased by 3.82% from Rs 1,690.05 million in Q4FY26. Business Highlights: Acquisition of ARAI: On May 14, 2026, the company acquired 100% of the paid-up equity share capital of ARAI Solutions Private Limited for a total cash consideration of Rs 110 million. Acquisition of TruBridge: On April 23, 2026, the company's US subsidiary, IKS Inc., entered into a definitive agreement to acquire TruBridge, Inc. for an enterprise value of up to USD 557 million. The acquisition was completed on July 9, 2026, subsequent to the end of Q1FY27. Revenue from Software Licenses: During Q1FY27, the company recognized revenue from a material pre-existing relationship with TruBridge, Inc. for the sale of certain software licenses. Increased Stake in IKS WWMG MSO: On June 30, 2026, IKS Inc. acquired an additional 3.86% equity interest in IKS WWMG MSO LLC, increasing the Group's aggregate shareholding from 48.02% to 51.88%, effectively making it a subsidiary. Leadership Succession: Mr. Berjis Desai is retiring as Non-Executive Chairman and Non-Independent Director at the conclusion of the 20th Annual General Meeting. The Board has designated Mr. Clarence Carleton King II to succeed him as the Non-Executive Chairman and Independent Director. Equity Allotment: During Q1FY27, the company allotted 1,40,085 shares to eligible employees following the exercise of options under the IKS Employees Stock Options Plan 2022. Sachin K. Gupta, Founder & Global CEO, IKS Health, said: "This quarter's results showcase the resilience of our business model, powered by strong client trust, operational efficiency, and a scalable care enablement platform. This continued momentum builds on a decade of profitable growth, marked by an impressive 46% PAT CAGR." “The acquisition of TruBridge marks an important milestone in our growth journey, expanding our capabilities and strengthening our ability to serve a broader range of healthcare organizations, including rural and community health systems. By bringing together complementary expertise, technology, and healthcare capabilities, we are well-positioned to create greater value for our clients and drive sustainable growth over the long term." Nithya Balasubramanian, Group CFO, IKS Health said: “We closed Q1FY27 with robust financial results, delivering 21% YoY revenue growth and a 28% YoY growth in PAT. These outcomes are a direct result of our unwavering focus on cost discipline, platform scalability, and capital efficiency. As we look to the rest of the fiscal year, our priority remains clear: protecting our margins while investing prudently in the strategic capabilities that secure long-term value.” Result PDF